Trading-Stocks.de

Normale Version: ABIOMED
Du siehst gerade eine vereinfachte Darstellung unserer Inhalte. Normale Ansicht mit richtiger Formatierung.
Healthcare | Medical Appliances & Equipment | USA

ABIOMED (ABMD) Q4 Earnings Meet Estimates, Sales Rise in Japan

ABIOMED, Inc. ABMD reported fourth-quarter fiscal 2019 earnings per share (EPS) of $1.07, which were in line with the Zacks Consensus Estimate. The bottom line rose 33.8% from the figure registered in the year-ago quarter.

The Zacks Rank #3 (Hold) company’s revenues came in at $207.1 million, missing the Zacks Consensus Estimate of $217.7 million. However, the metric improved 18.7% from the prior-year quarter.

FY19 at a Glance

Fiscal 2019 EPS came in at $5.61, beating the Zacks Consensus Estimate of $5.05. The figure skyrocketed 129% year over year.

...

https://finance.yahoo.com/news/abiomed-a...12032.html

[Bild: ABMDc1dl1616.png]